JP5546087B2 - 皮膚疾患経口治療または予防剤 - Google Patents

皮膚疾患経口治療または予防剤 Download PDF

Info

Publication number
JP5546087B2
JP5546087B2 JP2005036235A JP2005036235A JP5546087B2 JP 5546087 B2 JP5546087 B2 JP 5546087B2 JP 2005036235 A JP2005036235 A JP 2005036235A JP 2005036235 A JP2005036235 A JP 2005036235A JP 5546087 B2 JP5546087 B2 JP 5546087B2
Authority
JP
Japan
Prior art keywords
dgla
intake
therapeutic
gla
prophylactic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2005036235A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006219454A5 (enExample
JP2006219454A (ja
Inventor
法史 立石
洋 河島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Holdings Ltd
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Priority to JP2005036235A priority Critical patent/JP5546087B2/ja
Priority to EP06713928.7A priority patent/EP1852114B1/en
Priority to EP19183855.6A priority patent/EP3581178B1/en
Priority to CA2599112A priority patent/CA2599112C/en
Priority to PCT/JP2006/302787 priority patent/WO2006085687A1/ja
Priority to US11/884,199 priority patent/US9006287B2/en
Priority to CN2012100164426A priority patent/CN102600174A/zh
Priority to CN 200610003112 priority patent/CN101019853B/zh
Publication of JP2006219454A publication Critical patent/JP2006219454A/ja
Publication of JP2006219454A5 publication Critical patent/JP2006219454A5/ja
Application granted granted Critical
Publication of JP5546087B2 publication Critical patent/JP5546087B2/ja
Priority to US14/644,231 priority patent/US9943495B2/en
Priority to US15/911,806 priority patent/US10342773B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2005036235A 2005-02-14 2005-02-14 皮膚疾患経口治療または予防剤 Expired - Fee Related JP5546087B2 (ja)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP2005036235A JP5546087B2 (ja) 2005-02-14 2005-02-14 皮膚疾患経口治療または予防剤
EP19183855.6A EP3581178B1 (en) 2005-02-14 2006-02-10 Composition containing dihomo-(gamma)-linolenic acid (dgla) as active ingredient
CA2599112A CA2599112C (en) 2005-02-14 2006-02-10 Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient
PCT/JP2006/302787 WO2006085687A1 (ja) 2005-02-14 2006-02-10 ジホモ−γ−リノレン酸（ＤＧＬＡ）を有効成分として含んで成る組成物
US11/884,199 US9006287B2 (en) 2005-02-14 2006-02-10 Composition comprising dihomo-γ-linolenic acid (DGLA) as active ingredient
EP06713928.7A EP1852114B1 (en) 2005-02-14 2006-02-10 Composition containing dihomo-y-linolenic acid (dgla) as active ingredient
CN2012100164426A CN102600174A (zh) 2005-02-14 2006-02-14 含有有效成分二均-γ-亚麻酸(DGLA)的组成物
CN 200610003112 CN101019853B (zh) 2005-02-14 2006-02-14 含有有效成分二均-γ-亚麻酸(DGLA)的组成物
US14/644,231 US9943495B2 (en) 2005-02-14 2015-03-11 Composition containing dihomo-γ-linolenic acid (DGLA) as the active ingredient
US15/911,806 US10342773B2 (en) 2005-02-14 2018-03-05 Composition containing dihomo-γ-linolenic acid (DGLA) as the active ingredient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005036235A JP5546087B2 (ja) 2005-02-14 2005-02-14 皮膚疾患経口治療または予防剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012013311A Division JP2012082226A (ja) 2012-01-25 2012-01-25 皮膚疾患経口治療または予防剤

Publications (3)

Publication Number Publication Date
JP2006219454A JP2006219454A (ja) 2006-08-24
JP2006219454A5 JP2006219454A5 (enExample) 2008-03-27
JP5546087B2 true JP5546087B2 (ja) 2014-07-09

Family

ID=36981996

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005036235A Expired - Fee Related JP5546087B2 (ja) 2005-02-14 2005-02-14 皮膚疾患経口治療または予防剤

Country Status (2)

Country Link
JP (1) JP5546087B2 (enExample)
CN (1) CN101019853B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006287B2 (en) 2005-02-14 2015-04-14 Suntory Holdings Limited Composition comprising dihomo-γ-linolenic acid (DGLA) as active ingredient
JP2006306813A (ja) * 2005-04-28 2006-11-09 Suntory Ltd 肥満細胞増殖抑制剤
JP2006306812A (ja) * 2005-04-28 2006-11-09 Suntory Ltd 好酸球浸潤抑制剤
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
WO2012153832A1 (ja) 2011-05-12 2012-11-15 日本水産株式会社 炎症性疾患用皮膚外用組成物
US8936803B2 (en) * 2011-10-19 2015-01-20 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereof
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
US9855236B2 (en) 2011-10-19 2018-01-02 Ds Biopharma Limited Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereof
US9820484B2 (en) 2013-12-04 2017-11-21 Nippon Suisan Kaisha, Ltd. Dihomo-γ-linolenic acid-containing microbial oil and dihomo-γ-linolenic acid-containing microbial biomass
EP3151825B1 (en) 2014-06-04 2020-03-25 DS Biopharma Limited Pharmaceutical compositions comprising dgla and use of same
WO2017118911A1 (en) * 2016-01-07 2017-07-13 Dignity Sciences Limited Pharmaceutical compositions comprising dgla and use of same
MX379148B (es) * 2016-06-01 2025-03-10 Soc Des Produits Nestle S A Star Composición para usar en la profilaxis de enfermedades alérgicas.
US20180333382A1 (en) * 2017-05-19 2018-11-22 Ds Biopharma Limited Pharmaceutical compositions comprising dgla and use of same
CA3125314A1 (en) * 2018-12-28 2020-07-02 Nippon Suisan Kaisha, Ltd. Dihomo-.gamma.-linolenic acid-containing microbial oil/lipid with reduced arachidonic acid content
WO2021065659A1 (ja) * 2019-10-01 2021-04-08 サントリーホールディングス株式会社 アクアポリン３の発現調節を介した腸機能改善用組成物及びその使用
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases
JP2023058457A (ja) * 2021-10-13 2023-04-25 花王株式会社 炎症性皮膚疾患の予防、治療又は改善剤
CN118103039A (zh) * 2021-10-13 2024-05-28 花王株式会社 抗过敏剂
WO2023181755A1 (ja) * 2022-03-22 2023-09-28 東洋紡株式会社 皮膚機能関連因子に関する遺伝子の発現調節剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47777B1 (en) * 1978-01-23 1984-06-13 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
IE49783B1 (en) * 1979-05-18 1985-12-11 Efamol Ltd Pharmaceutical and dietary composition comprising epsilon-linolenic acids
GB8806737D0 (en) * 1988-03-22 1988-04-20 Efamol Holdings Therapeutic composition & method
JP2002047176A (ja) * 2000-08-04 2002-02-12 Idemitsu Technofine Co Ltd ＩｇＥ産生抑制剤

Also Published As

Publication number Publication date
CN101019853B (zh) 2013-05-15
JP2006219454A (ja) 2006-08-24
CN101019853A (zh) 2007-08-22

Similar Documents

Publication Publication Date Title
US10342773B2 (en) Composition containing dihomo-γ-linolenic acid (DGLA) as the active ingredient
JP5546087B2 (ja) 皮膚疾患経口治療または予防剤
JP7007010B2 (ja) 脂質含有組成物およびその使用方法
Kroes et al. A review of the safety of DHA45-oil
EP2682116B1 (en) Metabolic syndrome ameliorating agent
WO2008059965A1 (en) Agent for alleviating or preventing stress symptoms and agent for improving mental conditions
Bhat Functional Lipids as Nutraceuticals: A Review
JP6203320B2 (ja) 皮膚疾患経口治療または予防剤
JP2010105946A (ja) 筋タンパク質増強剤及びこれを含む医薬品または食品
JP2012082226A (ja) 皮膚疾患経口治療または予防剤
JP2013063937A (ja) Ｇｉｐ上昇抑制剤
JP6462790B2 (ja) 皮膚疾患経口治療または予防剤
JP2006306812A (ja) 好酸球浸潤抑制剤
JP6214474B2 (ja) 皮膚疾患経口治療または予防剤
JP2006306813A (ja) 肥満細胞増殖抑制剤
JP5759663B2 (ja) 皮膚バリア機能改善剤等
JP5479696B2 (ja) 生体内のプラスマローゲン増加剤
JP2024051305A (ja) 糖質燃焼促進剤
Nath et al. Role of Omega-3s in Functional Foods
EP3632422B1 (en) Composition comprising monounsaturated fatty acids having 20 or more carbon atoms for use in improving vascular endothelial function
Hernandez et al. Applications of omega-3 fats in foods
CN107970232A (zh) 含n-3系不饱和脂肪酸的组合物、及n-3系不饱和脂肪酸在该组合物的制造中的应用
JP2018168139A (ja) ｎ−３系不飽和脂肪酸を含む中性脂肪値の低減または上昇抑制用の組成物、並びに該組成物の製造におけるｎ−３系不飽和脂肪酸の使用
WO2008153220A1 (ja) 血管疾患の予防又は治療剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080213

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080213

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20090424

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110524

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110722

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20111025

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120125

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20120315

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20120427

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140310

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140513

R150 Certificate of patent or registration of utility model

Ref document number: 5546087

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees